Table 3 The relationship between expression of IGFBP-5 and cFLIP and clinicopathological parameters in CC
clinical parameter | n | IGFBP5 | n | cFLIP | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
- | + | % | P | - | + | % | P | |||
Lymph node metastasis | ||||||||||
existence | 12 | 10 | 2 | 16.67 | 12 | 2 | 10 | 83.33 | ||
Nonexistence | 28 | 12 | 16 | 57.14 | P < 0.05 | 28 | 5 | 23 | 82.14 | P > 0.05 |
Clinical stage | ||||||||||
Stage I | 26 | 11 | 15 | 57.69 | 26 | 6 | 20 | 72.92 | ||
Stage II | 14 | 11 | 3 | 21.43 | P < 0.05 | 14 | 1 | 13 | 92.86 | P > 0.05 |
Pathological differentiation | ||||||||||
well differentiated | 24 | 6 | 18 | 75.00 | 24 | 7 | 17 | 70.83 | ||
moderately or poorly differentiated | 16 | 12 | 4 | 25.00 | P < 0.05 | 16 | 0 | 16 | 100.0 | P < 0.05 |